Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Diphenyl Ether → Ethyl 4-[2-(8-chlorodibenz[b,f][1,4]oxazepin-10(11H)-yl)-3,4-dioxo-1-cyclobuten-1-yl]-1-phenyl-2-piperazinecarboxylate
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Diphenyl Ether | HCID 7583 | — |
| 반응물 | 8-Chloro-dibenz[b,f]-[1,4]oxazepine | HCID 838267 | — |
| 반응물 | Ethyl 4-(2-ethoxy-3,4-dioxo-1-cyclobuten-1-yl)-1-phenyl-2-piperazinecarboxylate | HCID 18961721 | — |
| 생성물 | Ethyl 4-[2-(8-chlorodibenz[b,f][1,4]oxazepin-10(11H)-yl)-3,4-dioxo-1-cyclobuten-1-yl]-1-phenyl-2-piperazinecarboxylate | HCID 15232292 | 43.8% |
반응 단계
A mixture of 8-chloro-dibenz[b,f][1,4]oxazepine (1.02 g) and the product of Example 3 (0.26 g) and diphenyl ether (3 mL) was heated to reflux for 1.75 hours. The mixture was rapidly filtered thourough a small column of silica gel and the filtrate was concentrated. The residue was purified by chromatography on silica gel to obtain the title compound (0.173 g).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US05354746 |
| 출처 데이터셋 | uspto-grants-1994_10 |
| ORD ID | ord-8896ec655f0f4652a1982053d00f9a88 |
| 출처 메모 | uspto-grants-1994_10 |